Management of newly diagnosed epilepsy: A practical guide to monotherapy

Michael A. Stein, Andres M Kanner

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

With the emergence of several new antiepileptic drugs (AEDs) in recent years, choosing an agent to initiate monotherapy in newly diagnosed epilepsy has become increasingly complicated. We provide a succinct guide intended for general clinicians to assist in this clinical situation. General features of AEDs, differences between first- and second-generation drugs, and characteristics specific to each medication are discussed. The emphasis is on tailoring treatment to the individual patient with epilepsy because each case has specific features that must be accounted for, including the type of seizure and epilepsy, medication-specific characteristics, co-morbid conditions, drug-drug interactions, patient drug tolerance, and special population factors, all of which must be balanced and optimized when choosing initial therapy in this setting. Finally, this information is conveniently summarized in a set of tables and illustrated by way of case scenarios.

Original languageEnglish (US)
Pages (from-to)199-222
Number of pages24
JournalDrugs
Volume69
Issue number2
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Epilepsy
Anticonvulsants
Drug Tolerance
Drug Interactions
Pharmaceutical Preparations
Seizures
Therapeutics
Population

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Management of newly diagnosed epilepsy : A practical guide to monotherapy. / Stein, Michael A.; Kanner, Andres M.

In: Drugs, Vol. 69, No. 2, 2009, p. 199-222.

Research output: Contribution to journalArticle

@article{194e73f1409e47f3a2f2649d21937a25,
title = "Management of newly diagnosed epilepsy: A practical guide to monotherapy",
abstract = "With the emergence of several new antiepileptic drugs (AEDs) in recent years, choosing an agent to initiate monotherapy in newly diagnosed epilepsy has become increasingly complicated. We provide a succinct guide intended for general clinicians to assist in this clinical situation. General features of AEDs, differences between first- and second-generation drugs, and characteristics specific to each medication are discussed. The emphasis is on tailoring treatment to the individual patient with epilepsy because each case has specific features that must be accounted for, including the type of seizure and epilepsy, medication-specific characteristics, co-morbid conditions, drug-drug interactions, patient drug tolerance, and special population factors, all of which must be balanced and optimized when choosing initial therapy in this setting. Finally, this information is conveniently summarized in a set of tables and illustrated by way of case scenarios.",
author = "Stein, {Michael A.} and Kanner, {Andres M}",
year = "2009",
doi = "10.2165/00003495-200969020-00005",
language = "English (US)",
volume = "69",
pages = "199--222",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "2",

}

TY - JOUR

T1 - Management of newly diagnosed epilepsy

T2 - A practical guide to monotherapy

AU - Stein, Michael A.

AU - Kanner, Andres M

PY - 2009

Y1 - 2009

N2 - With the emergence of several new antiepileptic drugs (AEDs) in recent years, choosing an agent to initiate monotherapy in newly diagnosed epilepsy has become increasingly complicated. We provide a succinct guide intended for general clinicians to assist in this clinical situation. General features of AEDs, differences between first- and second-generation drugs, and characteristics specific to each medication are discussed. The emphasis is on tailoring treatment to the individual patient with epilepsy because each case has specific features that must be accounted for, including the type of seizure and epilepsy, medication-specific characteristics, co-morbid conditions, drug-drug interactions, patient drug tolerance, and special population factors, all of which must be balanced and optimized when choosing initial therapy in this setting. Finally, this information is conveniently summarized in a set of tables and illustrated by way of case scenarios.

AB - With the emergence of several new antiepileptic drugs (AEDs) in recent years, choosing an agent to initiate monotherapy in newly diagnosed epilepsy has become increasingly complicated. We provide a succinct guide intended for general clinicians to assist in this clinical situation. General features of AEDs, differences between first- and second-generation drugs, and characteristics specific to each medication are discussed. The emphasis is on tailoring treatment to the individual patient with epilepsy because each case has specific features that must be accounted for, including the type of seizure and epilepsy, medication-specific characteristics, co-morbid conditions, drug-drug interactions, patient drug tolerance, and special population factors, all of which must be balanced and optimized when choosing initial therapy in this setting. Finally, this information is conveniently summarized in a set of tables and illustrated by way of case scenarios.

UR - http://www.scopus.com/inward/record.url?scp=60549115283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549115283&partnerID=8YFLogxK

U2 - 10.2165/00003495-200969020-00005

DO - 10.2165/00003495-200969020-00005

M3 - Article

C2 - 19228076

AN - SCOPUS:60549115283

VL - 69

SP - 199

EP - 222

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 2

ER -